Zone Model Predictive Control with Glucose- and Velocity-Dependent Control Penalty Adaptation for an Artificial Pancreas

An adaptive zone model predictive control design problem is considered for enhanced blood glucose regulation in patients with type 1 diabetes mellitus. The key contribution of this work is the development of a zone MPC with a dynamic cost function that updates its control penalty parameters based on the predicted glucose and its rate of change. A parameter adaptation law is proposed by explicitly constructing maps from glucose state and velocity spaces to control penalty parameter spaces. The proposed controller is tested on the to-patient cohort of the US Food and Drug Administration accepted Universities of Virginia/Padova simulator and compared with the zone model predictive control without parameter adaptation. The obtained in-silico results indicate that for unannounced meals, the controller leads to statistically significant improvements in terms of mean glucose level (154.2 mg/dL vs. 160.7 mg/dL; $\boldsymbol{p} < 0.001)$ and percentage time in the safe euglycemic range of [70, 180] mg/dL (72.7% vs. 67.5%; $\boldsymbol{p} < 0.001$) without increasing the risk of hypoglycemia (percentage time below 70 mg/dL, 0.0% vs. 0.0%; $\boldsymbol{p}=0.788$). For announced meals, the obtained performance is similar (and slightly superior) to that of the zone model predictive control without adaptation in terms of mean glucose level (135.6 mg/dL vs. 136.5 mg/dL; $\boldsymbol{p} < 0.001$), percentage time in [70, 180] mg/dL (91.2% vs. 90.9%; $\boldsymbol{p}=0.04$), and percentage time below 70 mg/dL (0.0% vs. 0.0%; $\boldsymbol{p}=0.346$).

[1]  C. Cobelli,et al.  The UVA/PADOVA Type 1 Diabetes Simulator , 2014, Journal of diabetes science and technology.

[2]  F. El-Khatib,et al.  Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Dual Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine , 2007, Journal of diabetes science and technology.

[3]  Eyal Dassau,et al.  Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial , 2017, Diabetes Care.

[4]  Eyal Dassau,et al.  Multi-Zone-MPC: Clinical Inspired Control Algorithm for the Artificial Pancreas , 2011 .

[5]  Ahmad Haidar,et al.  The Artificial Pancreas: How Closed-Loop Control Is Revolutionizing Diabetes , 2016, IEEE Control Systems.

[6]  R. Hovorka,et al.  Coming of age: the artificial pancreas for type 1 diabetes , 2016, Diabetologia.

[7]  Claudio Cobelli,et al.  Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results , 2018, IEEE Transactions on Biomedical Engineering.

[8]  Eyal Dassau,et al.  Zone Model Predictive Control: A Strategy to Minimize Hyper- and Hypoglycemic Events , 2010, Journal of diabetes science and technology.

[9]  Francis J. Doyle,et al.  A run‐to‐run framework for prandial insulin dosing: handling real‐life uncertainty , 2007 .

[10]  C. C. Palerm,et al.  A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes. , 2008, Journal of process control.

[11]  Eyal Dassau,et al.  Periodic-Zone Model Predictive Control for Diurnal Closed-Loop Operation of an Artificial Pancreas , 2013, Journal of diabetes science and technology.

[12]  Irl B. Hirsch,et al.  Multivariable adaptive identification and control for artificial pancreas systems , 2015 .

[13]  Eyal Dassau,et al.  Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes , 2016, Autom..

[14]  Eyal Dassau,et al.  Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control. , 2017, Diabetes technology & therapeutics.

[15]  Eyal Dassau,et al.  Switched LPV Glucose Control in Type 1 Diabetes , 2016, IEEE Transactions on Biomedical Engineering.

[16]  Dale E. Seborg,et al.  Control-Relevant Models for Glucose Control Using A Priori Patient Characteristics , 2012, IEEE Transactions on Biomedical Engineering.

[17]  Eyal Dassau,et al.  Closed-Loop Control of Artificial Pancreatic $\beta$ -Cell in Type 1 Diabetes Mellitus Using Model Predictive Iterative Learning Control , 2010, IEEE Transactions on Biomedical Engineering.

[18]  Eyal Dassau,et al.  Velocity-weighting & velocity-penalty MPC of an artificial pancreas: Improved safety & performance , 2018, Autom..

[19]  Ali Cinar,et al.  Adaptive control of artificial pancreas systems - a review. , 2014, Journal of healthcare engineering.

[20]  Eyal Dassau,et al.  Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial. , 2015, The Journal of clinical endocrinology and metabolism.

[21]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[22]  Lauren M. Huyett,et al.  Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms , 2014, Diabetes Care.

[23]  Eyal Dassau,et al.  Dynamic Insulin on Board: Incorporation of Circadian Insulin Sensitivity Variation , 2013, Journal of diabetes science and technology.